Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$6.16
-0.11-1.75%
At close: Dec 15, 4:00 PM EST
$6.53
0.376.01%
After Hours: Dec 11, 5:31 PM EST
Comments
Loading...
Eupraxia Pharmaceuticals (EPRX) Stock Price, Quote, News & History
EPRXNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Eupraxia Pharmaceuticals (EPRX) stock?
You can purchase shares of Eupraxia Pharmaceuticals (NASDAQ:EPRX) through any online brokerage.
Who are Eupraxia Pharmaceuticals (EPRX) competitors?
Other companies in Eupraxia Pharmaceuticals’s space includes: Tectonic Therapeutic Inc (NASDAQ:TECX), Larimar Therapeutics Inc (NASDAQ:LRMR), Palisade Bio Inc (NASDAQ:PALI), AC Immune SA (NASDAQ:ACIU) and Silence Therapeutics PLC (NASDAQ:SLN).
What is the forecast, or price target, for Eupraxia Pharmaceuticals (EPRX) stock?
Eupraxia Pharmaceuticals has a consensus price target of $10.67.
What is the current price for Eupraxia Pharmaceuticals (EPRX)?
The stock price for Eupraxia Pharmaceuticals (NASDAQ: EPRX) is $6.53 last updated December 11, 2025 at 5:31 PM EST.
Does Eupraxia Pharmaceuticals (EPRX) pay a dividend?
There are no upcoming dividends for Eupraxia Pharmaceuticals.
When is Eupraxia Pharmaceuticals (NASDAQ:EPRX) reporting earnings?
Eupraxia Pharmaceuticals does not have any upcoming earnings scheduled.
Is Eupraxia Pharmaceuticals (EPRX) going to split?
There is no upcoming split for Eupraxia Pharmaceuticals.
What sector and industry does Eupraxia Pharmaceuticals (EPRX) operate in?
Eupraxia Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
